A Multicenter Phase I Dose-Escalation Trial of a Novel Glutaminase Inhibitor Telaglenastat in Combination with Carfilzomib and Dexamethasone in Relapsed and Refractory Multiple Myeloma
Gonsalves W, Neparidze N, Allred J, Kumar S, Reid J, Shapiro G, Costello B, Piekarz R, Baz R, Devarakonda S. A Multicenter Phase I Dose-Escalation Trial of a Novel Glutaminase Inhibitor Telaglenastat in Combination with Carfilzomib and Dexamethasone in Relapsed and Refractory Multiple Myeloma. Blood 2022, 140: 7315-7316. DOI: 10.1182/blood-2022-164966.Peer-Reviewed Original Research